{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Zebulon",
      "state": "NC",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "63691",
      "recalling_firm": "GlaxoSmithKline, LLC.",
      "address_1": "1011 North Arendell Ave",
      "address_2": "N/A",
      "postal_code": "27597-1217",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide",
      "recall_number": "D-068-2013",
      "product_description": "Arranon (nelarabine) Injection 5mg/mL, 50mL Vials, Rx only,  For I.V. Infusion only, GlaxoSmith Kline, Research Triangle Park, NC 27709. Made in England, NDC 0007-4401-06",
      "product_quantity": "1,319 vials",
      "reason_for_recall": "Impurities/Degradation Products: Potential for drug related impurities to exceed the specification limits.",
      "recall_initiation_date": "20121008",
      "center_classification_date": "20121127",
      "termination_date": "20140911",
      "report_date": "20121205",
      "code_info": "Lot # C536707 Exp 02/14, C538830 Exp.02/14,  C533169 Exp. 02/14"
    }
  ]
}